Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $16.8000 (-5.03%) ($16.7500 - $17.6700) on Thu. Jun. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.31% (three month average) | RSI | 27 | Latest Price | $16.8000(-5.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.9% a day on average for past five trading days. | Weekly Trend | TGTX declines -7.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(64%) ARKG(59%) ARKK(56%) IBB(55%) IWO(55%) | Factors Impacting TGTX price | TGTX will decline at least -4.155% in a week (0% probabilities). VIXM(-34%) VXX(-32%) UUP(-17%) DRIV(-3%) XLC(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.155% (StdDev 8.31%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
1 - 5 Day Possible Target | $4.96(-70.48%) | Resistance Level | $19.06 | 5 Day Moving Average | $17.78(-5.51%) | 10 Day Moving Average | $17.99(-6.61%) | 20 Day Moving Average | $19.06(-11.86%) | To recent high | -23.1% | To recent low | 135.3% | Market Cap | $2.128b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |